Navigation Links
AMDL Inc. Announces Second Closing of Private Placement of Series 2 Senior Notes
Date:6/15/2009

ements. The Company cautions readers not to place undue reliance on any forward-looking statements. The Company does not undertake, and specifically disclaims any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

    AMDL Contact:
    Kristine Szarkowitz
    Director-Investor Relations
    kszarkowitz@amdl.com
    Tel :) 206.310.5323


'/>"/>
SOURCE AMDL Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. HPV Vaccine Acceptability Study Announces Results
2. Endologix Announces Live Web Cast of Presentation in SMH Capital Small Cap Spotlight on June 17, 2009 at 4:15 p.m. ET
3. American Hospital Management Company Announces the Opening of the New HOSPITAL UNIVERSITARIO DEL RIO-HOSPIRIO in Cuenca, Ecuador
4. Providence Service Corporation Announces Preliminary Results of Annual Meeting of Stockholders
5. New Online Community Answers Hospital Questions about ARRA QHR Announces Launch of theQsphere.com
6. Medizone Announces That Its AsepticSure(TM) Development Program is Reaching Objectives on Two Fronts
7. PDI, Inc. Announces New Business Wins Exceeding $18 Million
8. Pulmo BioTech Inc. Announces Fund Raising Agreement with Moody Capital Solutions, Inc.
9. Eli Lilly and Company Announces New Drug Discovery Initiative
10. QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy
11. NBTY Announces Preliminary Unaudited Net Sales Results for May 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...tudy finds myriad microbes in tobacco, but risk is...y News) -- New research provides evidence that th...ing bacteria that cause respiratory disease. , ... out, the authors of the new study aren,t sure wha...bacteria is nothing new: Microbes surround us ever...
(Date:12/2/2009)..., Scientists may not be able to tell a good book ...of an old book by its smell. In a report in ACS, ...y describe development of a new test that can meas...orical documents based on their smell. The nondest...ums preserve a range of prized paper-based objects...
(Date:12/2/2009)..., , WASHINGTON, Dec. 2 Holl...al Media and Stakeholder Management for Kaiser Per...R News, PR People luncheon held at the National P...petition showcases the top innovators and professi...ions matter in the marketplace. The winners of thi...
(Date:12/2/2009)..., , Media Advisory for Thursday, Dec. 3 ,... Speak at Luncheon Meeting of Army Wounded Warrior...Helps Vets Adjust ,, WASHINGTON, Dec. 2 /PRNew...day by the National Organization on Disability: ,... from the Army Wounded Warrior (AW2) program,s Nat...
(Date:12/2/2009)...ouse study suggests the gene could be linked to li...HealthDay News) -- Sperm genes may affect life spa...in why females tend to live longer than males, Jap...hat mice created using two female genomes -- bi-ma... than mice created from the normal combination of ...
Breaking Medicine News(10 mins):Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2
...Scots are at a high risk of developing diabetics. ...s on the rise. Statistics show that in the next 25...uffer from diabetes. The Scottish Executives are ...measures. So far the number of people diagnose...
...Health Service Plans for the Northeast have been a...egional hospital is expected to be opened by 2015/...northeast are located in Dundalk, Drogheda, Navan,...lth care system in the region. The existing se...
...The Brihanmumbai Municipal Corporation’s (BMC) Hea...a medical team and conducted health camps// Chamun...ses of malnutrition have been reported. Their repo...ours later, found three children suffering from ma...
...A new study in the July 15 issue of Clinical Infec...s known as statins could be very useful// in the e...ly available. Statins lower "bad" cholestero...ucing inflammation. Recent studies suggest that th...
...Acting tough on the medicos who had resorted to th...stitutions, Health Minister Anbumani Ramadoss toda...e strike period was not a punishment. 'It is ...y medicos at the AIIMS for not getting their salar...
...The National Cadet Corps will soon sign an MoU wit...s on HIV and AIDS in India, Director General of NC...ed to be created among the HIV infected that there...ntrolling the spread of drug addiction would also ...
Other Medicine News:Health News:Children In Slums Of Mumbai Might be Suffering From Malnutrition 2Health News:Statins Could Play Important Role In Influenza Pandemic 2
(Date:12/2/2009)..., , EAST HANOVER, N.J., Dec. 2 /PR...a, including a late-breaking presentation on Tasig...chronic myeloid leukemia, demonstrate the strength...g the care of patients. ,, The new data, at th... Meeting and Exposition, highlight the company,s c...
(Date:12/1/2009)..., , NEW YORK, Dec . 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ... ,, http://www.reportlinker.com/p0164247/Insul..., Insulin pumps, also called Continuous Subcutan...ol over diabetes, when compared to other forms of ...
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswire/ -...earch report is available in its catalogue: ,, ...eview ,, http://www.reportlinker.com/p0164366....html ,, Over the years, Liquid Chromatography...ences, pharmaceuticals, food and beverage, researc...
Breaking Medicine Technology:Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 2Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 3Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 4Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 5Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 6Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 7Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 8Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 9Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 10Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 11Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 12Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 13Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 14Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 15Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 16Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 17Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 18Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 19Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 20Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 21Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 22Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 23Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 24Significant potential of late- and mid-stage Novartis hematology portfolio to be showcased at upcoming ASH meeting 25Reportlinker Adds Insulin Pumps (External) - A World Market Review 2Reportlinker Adds Insulin Pumps (External) - A World Market Review 3Reportlinker Adds Insulin Pumps (External) - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7Overweight kids experience more loneliness anxiety MU study finds 50660 1Overweight kids experience more loneliness anxiety MU study finds 50660 2Natural compound stops retinopathy 9106 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 1Ben Gurion U researchers reveal connection between cancer and human evolution 9104 2
...k Buyer for Marketed Parenteral Product Ganite(R),...ated,(Nasdaq: GNTA ) today announced that the Com...on covering novel pharmaceutical gallium compositi...ent Office. Issued U.S.,Patent 7,354,952 extends t... franchise of oral gallium-containing products tha...
...Developed and Validated Clinically at Clinical Lab...Laboratory at the University of Ca...cs Expects Three Tests Applying its MicroRNA Techn...ertified Labs During 2008, REHOVOT, Israel and JE... Ltd. (Nasdaq: ROSG ), a leader in,the development...
Other Medicine Technology:Genta Receives Key Patent Related to Oral Gallium Compound G4544 2Genta Receives Key Patent Related to Oral Gallium Compound G4544 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 2Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 3Rosetta Genomics Signs Agreement With West Coast CLIA Certified Lab to Develop and Validate Tests Applying Company's MicroRNA Technology 4
Orrison's Medical Imaging Consultant for PDA
Schwartz Principles of Surgery PDA Edition
Sanford Guide to HIV/AIDS Therapy 2004
LyteMeister
Medicine Products: